Capmatinib is an oral, selective, and potent small-molecule inhibitor of the mesenchymal-epithelial transition (MET) tyrosine kinase, used in the treatment of metastatic non-small cell lung cancer harboring MET exon 14 skipping mutations.
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea